Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study.

@article{Tobin2011HomocysteineSA,
  title={Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study.},
  author={A-M Tobin and Rosalind Hughes and Eric Hand and Tora Leong and Ian M. Graham and Brian Kirby},
  journal={Clinical and experimental dermatology},
  year={2011},
  volume={36 1},
  pages={19-23}
}
BACKGROUND Psoriasis is a hyperproliferative, cutaneous disorder with the potential to lower levels of folate. This may result in raised levels of homocysteine, an independent risk factor for the development of cardiovascular disease. OBJECTIVE A study was conducted to compare levels of red-cell folate (RCF) and homocysteine in patients with psoriasis and in healthy controls. Levels of homocysteine were also examined in the context of other major cardiovascular risk factors. METHODS In… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Homocysteine plasmatic status in patients with psoriasis.

European journal of dermatology : EJD • 2011
View 4 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 24 references

Heart disease in psoriasis.

Journal of the American Academy of Dermatology • 2007

Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based casecontrol study

P Gisondi, G Tesari, A Conti
Br J Dermatol • 2007

Similar Papers

Loading similar papers…